|
Volumn 66, Issue 6, 2007, Pages 838-839
|
N-terminal prohormone brain natriuretic peptide: A biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis? [4]
c
Oligene GmbH
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;
BIOLOGICAL MARKER;
BRAIN NATRIURETIC PEPTIDE;
CYCLOOXYGENASE 2 INHIBITOR;
GLUCOCORTICOID;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
VALDECOXIB;
ACUTE HEART INFARCTION;
ADD ON THERAPY;
ARTHROPATHY;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
COMBINATION CHEMOTHERAPY;
CORONARY ARTERY DISEASE;
DRUG WITHDRAWAL;
FOOD AND DRUG ADMINISTRATION;
HEART FAILURE;
HUMAN;
HYPERTENSION;
LETTER;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
STROKE;
AGED;
ARTHRITIS, RHEUMATOID;
BIOLOGICAL MARKERS;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NATRIURETIC PEPTIDE, BRAIN;
OSTEOARTHRITIS;
PEPTIDE FRAGMENTS;
PROGNOSIS;
|
EID: 34249802051
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.2006.066522 Document Type: Letter |
Times cited : (11)
|
References (6)
|